Barclays Maintains Overweight on MetLife, Raises Price Target to $111

Barclays analyst Alex Scott has maintained an Overweight rating on MetLife (NYSE: MET) and increased the price target from $97 to $111. This adjustment reflects a positive outlook on the company's performance.